| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
ATHA (ATHA) has 6 insiders with recent SEC Form 4 filings, including 6 buys and 5 sells. ATHA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 329.8K | $2.09M | - | |
| CEO | 40.8K | $280.9K | - | |
| Other | 20.7K | $142.3K | - | |
| Other | 14.0K | $96.2K | - | |
| CFO | 12.9K | $88.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Gengos Andrew67 | See Below | Sell | 1,208 | $2.91 | $3,515.28 | -1.4% | |
| Dec 28, 2022 | Mileson Glenna | Chief Financial Officer | Buy | 50,000 | $2.85 | $142,250.00 | +45.5% | |
| Dec 2, 2022 | Romano Kelly A | Director | Buy | 30,000 | $3.29 | $98,700.00 | +360.8% | |
| Nov 15, 2022 | Moebius Hans | Chief Medical Officer | Buy | 5,000 | $3.29 | $16,442.00 | +8.2% | |
| Jun 30, 2022 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 1,371,362 | $2.99 | $4,100,372.38 | +19.3% | |
| Jun 28, 2022 | Moebius Hans | Chief Medical Officer | Buy | 10,000 | $2.88 | $28,800.00 | +23.3% | |
| Jun 23, 2022 | Worthington Mark | General Counsel | Sell | 2,614 | $2.69 | $7,031.66 | -12.0% | |
| Jun 23, 2022 | Mileson Glenna | Chief Financial Officer | Sell | 2,614 | $2.69 | $7,031.66 | -2.3% | |
| Jun 23, 2022 | Litton Mark James | Chief Executive Officer | Sell | 7,960 | $2.69 | $21,412.40 | -5.8% | |
| Jun 23, 2022 | Lenington Rachel | Chief Operating Officer | Sell | 4,193 | $2.69 | $11,279.17 | -41.9% |